Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and Gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo
B. Palermo et al., Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and Gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo, J INVES DER, 117(2), 2001, pp. 326-332
Vitiligo is a common skin disease characterized by the presence of well cir
cumscribed, depigmented, milky white macules devoid of identifiable melanoc
ytes. Although the detection of circulating anti-melanocytic antibodies and
of infiltrating lymphocytes at the margin of lesions supports the view tha
t vitiligo is an autoimmune disorder, its etiology remains unknown. In part
icular, it is still a matter of debate whether the primary pathogenic role
is exerted by humoral or cellular abnormal immune responses. In this study,
the presence of specific cytotoxic T lymphocyte responses against the mela
nocyte differentiation antigens Melan-A/MART1, tyrosinase, and gp100 in vit
iligo patients have been investigated by the use of major histocompatibilit
y complex/peptide tetramers. High frequencies of circulating melanocyte-spe
cific CD8(+) T cells were found in all vitiligo patients analyzed. These ce
lls exerted anti-melanocytic cytotoxic activity in vitro and expressed skin
-homing capacity. In one patient melanocyte-specific cells were characteriz
ed by an exceptionally high avidity for their peptide/major histocompatibil
ity complex ligand. These findings strongly suggest a role for cellular imm
unity in the pathogenesis of vitiligo and impact on the common mechanisms o
f self tolerance.